140 related articles for article (PubMed ID: 12774849)
21. Cannabinoid receptor-mediated inhibition of calcium signaling in rat retinal ganglion cells.
Lalonde MR; Jollimore CA; Stevens K; Barnes S; Kelly ME
Mol Vis; 2006 Oct; 12():1160-6. PubMed ID: 17093402
[TBL] [Abstract][Full Text] [Related]
22. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoids enhance N-methyl-D-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices.
Mendiguren A; Pineda J
Neurosci Lett; 2004 Jun; 363(1):1-5. PubMed ID: 15157983
[TBL] [Abstract][Full Text] [Related]
24. Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries.
Vanheel B; Van de Voorde J
J Pharmacol Exp Ther; 2001 Feb; 296(2):322-8. PubMed ID: 11160613
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid-induced changes in respiration of brain mitochondria.
Fišar Z; Singh N; Hroudová J
Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
[TBL] [Abstract][Full Text] [Related]
26. Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids.
Sade H; Muraki K; Ohya S; Hatano N; Imaizumi Y
Am J Physiol Cell Physiol; 2006 Jan; 290(1):C77-86. PubMed ID: 16107501
[TBL] [Abstract][Full Text] [Related]
27. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork.
Stumpff F; Boxberger M; Krauss A; Rosenthal R; Meissner S; Choritz L; Wiederholt M; Thieme H
Exp Eye Res; 2005 May; 80(5):697-708. PubMed ID: 15862177
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord.
Morisset V; Urban L
J Neurophysiol; 2001 Jul; 86(1):40-8. PubMed ID: 11431486
[TBL] [Abstract][Full Text] [Related]
31. A real time screening assay for cannabinoid CB1 receptor-mediated signaling.
Andersen HK; Piroli GG; Walsh KB
J Pharmacol Toxicol Methods; 2018; 94(Pt 1):44-49. PubMed ID: 29730318
[TBL] [Abstract][Full Text] [Related]
32. Sex differences in the cannabinoid modulation of an A-type K+ current in neurons of the mammalian hypothalamus.
Tang SL; Tran V; Wagner EJ
J Neurophysiol; 2005 Oct; 94(4):2983-6. PubMed ID: 15901756
[TBL] [Abstract][Full Text] [Related]
33. Effects of cannabinoids on synaptic transmission in the frog neuromuscular junction.
Sánchez-Pastor E; Trujillo X; Huerta M; Andrade F
J Pharmacol Exp Ther; 2007 May; 321(2):439-45. PubMed ID: 17267583
[TBL] [Abstract][Full Text] [Related]
34. The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.
Nilsson O; Fowler CJ; Jacobsson SO
Eur J Pharmacol; 2006 Oct; 547(1-3):165-73. PubMed ID: 16928371
[TBL] [Abstract][Full Text] [Related]
35. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Yang ZM; Paria BC; Dey SK
Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
Shivachar AC
Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
[TBL] [Abstract][Full Text] [Related]
37. Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands.
Bajo M; Roberto M; Schweitzer P
J Neurosci Res; 2009 Feb; 87(3):766-75. PubMed ID: 18816788
[TBL] [Abstract][Full Text] [Related]
38. SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity.
Pan X; Ikeda SR; Lewis DL
Mol Pharmacol; 1998 Dec; 54(6):1064-72. PubMed ID: 9855635
[TBL] [Abstract][Full Text] [Related]
39. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.
Malinowska B; Kwolek G; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):562-9. PubMed ID: 11770012
[TBL] [Abstract][Full Text] [Related]
40. Endogenous cannabinoid anandamide directly inhibits voltage-dependent Ca(2+) fluxes in rabbit T-tubule membranes.
Oz M; Tchugunova YB; Dunn SM
Eur J Pharmacol; 2000 Sep; 404(1-2):13-20. PubMed ID: 10980258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
